Lv3
316 积分 2024-08-03 加入
The Trop-2-targeting antibody drug conjugate DB-1305 has higher antitumor activity and a potentially better safety profile compared with DS-1062
5小时前
已完结
USP1 inhibition: A journey from target discovery to clinical translation
3个月前
已完结
4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
3个月前
已完结
Targeting ATR in patients with cancer
3个月前
已完结
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted Cancers
3个月前
已完结
Synthetic lethality in cancer drug discovery: challenges and opportunities
3个月前
已完结
Prevalence of KRAS Amplification in Patients with Metastatic Cancer: Real-world Next-Generation Sequencing Analysis
4个月前
已完结
Prevalence of KRAS Amplification in Patients with Metastatic Cancer: Real-world Next-Generation Sequencing Analysis
4个月前
已完结
SMARCA2 protein: structure, function and perspectives of drug design
4个月前
已完结
Olaparib-associated toxicity in cancer patients: a systematic review and meta-analysis
4个月前
已完结
皖公网安备34019202002308
